Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema (vol 23, pg 1066, 2009)

被引：0
|
作者：
Garcia-Arumi, J.
Fonollosa, A.
Macia, C.
Hernandez, C.
Martinez-Castillo, V.
Boixadera, A.
Zapata, M. A.
Simo, R.
机构：
来源：
EYE | 2009年 / 23卷 / 08期
关键词：
D O I：
10.1038/eye.2009.128
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Correction to: Eye (2009) 23, 1066–1071; doi:10.1038/eye.2008.230; published online 1 August 2008 The author name J García-Arumí was published incorrectly in the above referenced paper. The correct author list is shown above. The authors would like to apologize for this error.
引用
收藏
页码：1754 / 1754
页数：1
相关论文
共 50 条
  • [31] Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion:: a pilot study
    Krepler, K
    Ergun, E
    Sacu, S
    Richter-Müksch, S
    Wagner, J
    Stur, M
    Wedrich, A
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2005, 83 (05): : 600 - 604
  • [32] Study of aqueous humour inflammatory mediators' levels in a cohort of Egyptian patients with diabetic macular oedema
    Gomaa, Amir Ramadan
    Bedda, Ahmed Magdy
    Elgoweini, Hesham Fouad
    Taleb, Raghda Saad Zaghloul
    Saleh, Ahmed Mahmoud Abdelrahman
    BMC OPHTHALMOLOGY, 2023, 23 (01)
  • [33] Study of aqueous humour inflammatory mediators’ levels in a cohort of Egyptian patients with diabetic macular oedema
    Amir Ramadan Gomaa
    Ahmed Magdy Bedda
    Hesham Fouad ElGoweini
    Raghda Saad Zaghloul Taleb
    Ahmed Mahmoud Abdelrahman Saleh
    BMC Ophthalmology, 23
  • [34] Aqueous humour levels of vascular endothelial growth factor and erythropoietin in patients with diabetic macular oedema before and after intravitreal erythropoietin injection
    Lim, Ji W.
    Han, Jae R.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (06): : 537 - 544
  • [35] The efficacy of intra-vitreal triamcinolone for the treatment of macular oedema in diabetic maculopathy and non-ischaemic central and branch retinal vein occlusions
    Cohen, VM
    Obikpo, RK
    Glenn, AM
    Jones, CD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [36] Comment on: 'Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab'
    Calugaru, D.
    Calugaru, M.
    EYE, 2016, 30 (05) : 766 - 766
  • [37] The efficacy of intravitreal ranibizumab for the treatment of macular oedema secondary to retinal vein occlusions in a treatment-naive cohort: 6-month outcomes
    Laginaf, Masara
    Lewis, Adam
    Chandran, Manju
    Menon, Geeta
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [38] Comparative efficacy and safety of approved treatments for macular oedema secondary to branch retinal vein occlusion: a network meta-analysis
    Regnier, Stephane A.
    Larsen, Michael
    Bezlyak, Vladimir
    Allen, Felicity
    BMJ OPEN, 2015, 5 (06):
  • [39] Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: a pilot study
    Liang, Xiao-Ling
    Chen, Hao-Yu
    Huang, Yong-Sheng
    Eong, Kah-Guan Au
    Yu, Shan-Shan
    Liu, Xing
    Yan, Hong
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2007, 36 (04) : 293 - 297
  • [40] Photobiomodulation in the treatment of patients with non-centerinvolving diabetic macular oedema (vol 98, pg 1013, 2014)
    Tang, J.
    Herda, A. A.
    Kern, T. S.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (10) : 1463 - 1463
12345